Michael S. Weiss - Dec 29, 2021 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
CEO and President, Director
Signature
/s/ Michael S. Weiss
Stock symbol
TGTX
Transactions as of
Dec 29, 2021
Transactions value $
-$1,282,527
Form type
4
Date filed
1/7/2022, 05:00 PM
Previous filing
Jul 8, 2021
Next filing
Apr 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX COMMON STOCK Gift $0 -3K -0.02% $0.00 14.1M Dec 15, 2021 Direct F1
transaction TGTX COMMON STOCK Gift $0 -700K -4.95% $0.00 13.4M Dec 16, 2021 Direct F2
transaction TGTX COMMON STOCK Gift $0 -9K -0.07% $0.00 13.4M Dec 16, 2021 Direct F1
transaction TGTX COMMON STOCK Award $0 +56.4K +0.42% $0.00 13.5M Dec 29, 2021 Direct F3
transaction TGTX COMMON STOCK Sale -$721K -37.5K -0.28% $19.20 13.5M Jan 4, 2022 Direct F4
transaction TGTX COMMON STOCK Sale -$562K -30.7K -0.28% $18.31 11M Jan 5, 2022 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the transfer of shares of TG Therapeutics stock as a bona fide gift to various 501(c)(3) charitable organizations.
F2 Reflects the transfer of shares of TG Therapeutics stock to various trusts for the benefit of Mr. Weiss' dependents.
F3 Reflects a grant of restricted shares of common stock of TG Therapeutics in lieu of cash compensation owed to Mr. Weiss for the 2021 fiscal year, which will fully vest on January 1, 2024.
F4 In connection with the vesting of 225,000 shares held by Mr. Weiss' dependents on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy tax withholding obligations. Mr. Weiss nor his dependents had any discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F5 Includes 2,437,005 shares received as a liquidating distribution from Opus Point Partners, LLC ("Opus"), of which Mr. Weiss was a principal. In prior reports, Mr, Weiss reported beneficial ownership of all 4,874,010 shares held by Opus, even though he only owned 50% of Opus. On December 29, 2021, as part of the dissolution of Opus the shares of TGTX held by Opus were distributed to the underlying Opus owners. As a result of such distribution, the 2,437,005 shares held indirectly by the reporting person are no longer held by the reporting person.